CMND - Clearmind Medicine Inc.


2.29
-0.140   -6.114%

Share volume: 63,790
Last Updated: 12-24-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.11%

PREVIOUS CLOSE
CHG
CHG%

$2.43
-0.14
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
-11.58%
1 Month
1,331.25%
3 Months
116.04%
6 Months
154.47%
1 Year
46.79%
2 Year
-24.42%
Key data
Stock price
$2.29
P/E Ratio 
0.00
DAY RANGE
$2.23 - $2.43
EPS 
N/A
52 WEEK RANGE
$0.07 - $3.25
52 WEEK CHANGE
$46.79
MARKET CAP 
844.198 K
YIELD 
N/A
SHARES OUTSTANDING 
3.170 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
06-12-2025
BETA 
1.62
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$293,317
AVERAGE 30 VOLUME 
$15,428,730
Company detail
CEO: Adi Zuloff-Shani
Region: US
Website: clearmindmedicine.com
Employees: 0
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

N/A

Recent news